FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to the preparation of a polypeptide binding to death receptor 5 (DR5), and can be used in medicine.
EFFECT: resulting polypeptide contains many DR5-binding domains (DR5BD) representing VHH and can be used in effective cancer therapy or to reduce the number of regulatory T cells.
41 cl, 9 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-DR5 ANTIBODY AND USE THEREOF | 2018 |
|
RU2735956C1 |
| MULTIVALENT AND MULTI-SPECIFIC 41BB-BINDING FUSED PROTEINS | 2017 |
|
RU2789648C2 |
| BISPECIFIC ANTIBODIES | 2020 |
|
RU2818588C2 |
| PROGRAMMED CELL DEATH (PD-1) PROTEIN-1 ANTIBODIES AND USE THEREOF | 2017 |
|
RU2725950C1 |
| ANTIBODIES AGAINST CXCR2 AND THEIR USE | 2019 |
|
RU2807067C2 |
| ADAM9-BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2783619C2 |
| COMPOSITION FOR PREVENTION AND TREATMENT OF SKIN DISEASE CONTAINING SUBSTANCE SPECIFICALLY BINDING WITH VIMENTINE DERIVATIVE PEPTIDE | 2018 |
|
RU2751486C1 |
| AGE ANTIBODIES AND THEIR APPLICATION METHODS | 2016 |
|
RU2766209C2 |
| IL-12 HETERODIMERIC FC FUSION PROTEINS | 2019 |
|
RU2819097C2 |
| HYBRID PROTEINS OF sPD-1-Fc VARIANT | 2019 |
|
RU2785993C2 |
